Added to YB: 2025-10-30
Pitch date: 2025-09-30
HIK.L [bullish]
Hikma Pharmaceuticals PLC
-13.52%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.
Market Cap
GBP 4.6B
Pitch Price
GBP 17.38
Price Target
N/A
Dividend
4.08%
EV/EBITDA
7.61
P/E
12.33
EV/Sales
1.83
Sector
Pharmaceuticals
Category
value
Show full summary:
Diamond Hill International Strategy New Position: Hikma Pharmaceuticals PLC
HIK.L (new position): UK pharma co strong in sterile injectables & emerging markets. Margin pressures from FX/logistics created attractive entry. Expect valuation improvement as product launches & contract manufacturing ramp up.
Read full article (1 min)